JULIE MEANS MD NPI 1982703328

NPI Information

  • NPI: 1982703328
  • Provider Name: JULIE MEANS, MD
  • Classification: Internal Medicine - 207RX0202X
  • Specialization: Medical Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 4488 CAROTHERS PKWY STE 300
    FRANKLIN, TN
    ZIP 37067
  • Phone: (615) 591-4764

Map and Directions

Get Directions

NPI Details

Julie Means, MD is a medical oncology internal medicine in Franklin, TN with 29 years of experience. The provider is an internist who specializes in the diagnosis and treatment of all types of cancer and other benign and malignant tumors. This specialist decides on and administers therapy for these malignancies as well as consults with surgeons and radiotherapists on other treatments for cancer. Julie Means, MD NPI is 1982703328. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

Education
Medical School: BRODY SCHOOL OF MEDICINE AT EAST CAROLINA UNIVERSITY
Graduation Year:1997

The provider's business location address is:

4488 CAROTHERS PKWY STE 300
FRANKLIN, TN
ZIP 37067-583
Phone: (615) 591-4764
Fax: (615) 591-7947

The NPI 1982703328 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
  • Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, paclitaxel, 1 mg (HCPCS:J9267)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Injection, pegfilgrastim, excludes biosimilar, 0.5 mg (HCPCS:J2506)
  • Iron level (HCPCS:83540)
  • Iron binding capacity (HCPCS:83550)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Ferritin (blood protein) level (HCPCS:82728)
  • Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
  • Injection, carboplatin, 50 mg (HCPCS:J9045)
  • Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
  • Folic acid level, serum (HCPCS:82746)
  • Injection, zoledronic acid, 1 mg (HCPCS:J3489)
  • Gammaglobulin (immune system protein) measurement (HCPCS:82784)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Lactate dehydrogenase (enzyme) level (HCPCS:83615)
  • Vitamin d-3 level (HCPCS:82306)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a (HCPCS:G9678)
  • Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Measurement of immunoglobulin light chains (HCPCS:83521)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
  • Injection, fosnetupitant 235 mg and palonosetron 0.25 mg (HCPCS:J1454)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
  • Protein measurement, serum (HCPCS:84165)
  • Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
  • Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)
  • Magnesium level (HCPCS:83735)
  • Thyroxine (thyroid chemical), free (HCPCS:84439)
  • Cortisol (hormone) measurement, total (HCPCS:82533)
  • Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
  • Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month (HCPCS:99426)
  • Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
  • Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
  • Application of on-body injector for under skin injection (HCPCS:96377)
  • Immunologic analysis for detection of tumor antigen, quantitative; ca 125 (HCPCS:86304)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Automated urinalysis test (HCPCS:81003)
  • Erythropoietin (protein) level (HCPCS:82668)
  • Irrigation of implanted venous access drug delivery device (HCPCS:96523)
  • Uric acid level, blood (HCPCS:84550)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
  • Infusion into a vein for hydration, each additional hour (HCPCS:96361)
  • Drawing of blood for a medical problem (HCPCS:99195)
  • Red blood count, automated test (HCPCS:85045)
  • Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
  • Stool analysis for blood, by peroxidase activity (HCPCS:82272)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Haptoglobin (serum protein) level (HCPCS:83010)
  • Red blood cell sedimentation rate, to detect inflammation, automated (HCPCS:85652)
  • Beta-2 microglobulin (protein) level (HCPCS:82232)
  • Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)

The enumeration date for this NPI number is 9/22/2006 and was last updated on 10/3/2019.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RH0000XInternal MedicineHematologyMD36803TENNESSEENo
2207RX0202XInternal MedicineMedical Oncology36803TENNESSEEYes

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.